ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 391

$973K Total Retail Price of All Prescriptions

Rank: 12 out of 391

913 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Texas
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 913 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

1% of this provider’s 9,622 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 56%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $166 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Texas
SPIRIVA 584 498 1 1
PREDNISONE 520 425 2 3
PROAIR HFA 400 292 3 5
SIMVASTATIN 398 377 4 11
ENALAPRIL MALEATE 393 346 5 37
HYDROCODONE-ACETAMINOPHEN 371 255 S3 6 6
AMLODIPINE BESYLATE 367 303 7 14
LEVOTHYROXINE SODIUM 330 296 8 10
FUROSEMIDE 317 270 9 8
SYMBICORT 292 245 10 4
AZITHROMYCIN 266 211 11 9
LISINOPRIL 190 168 12 16
ADVAIR DISKUS 190 141 12 2
METFORMIN HCL 180 138 14 18
WARFARIN SODIUM 178 152 15 27
PRAVASTATIN SODIUM 167 123 16 40
METOPROLOL TARTRATE 167 118 16 25
ATORVASTATIN CALCIUM 154 132 18 28
ISOSORBIDE MONONITRATE ER 152 122 19 69
POTASSIUM CHLORIDE 150 119 20 21
GABAPENTIN 150 105 20 26
CITALOPRAM HBR 145 115 22 50
HYDROCHLOROTHIAZIDE 137 127 23 35
CLOPIDOGREL 125 104 24 43
NEXIUM 124 107 25 23
GLIMEPIRIDE 123 121 26 73
OMEPRAZOLE 120 82 27 12
CARVEDILOL 111 97 28 48
CRESTOR 109 83 29 41
CLONIDINE HCL 109 93 29 54
QVAR 104 80 31 103
COMBIVENT 103 68 32 17
TRAMADOL HCL 102 87 33 29
LEVOFLOXACIN 96 78 34 22
ATENOLOL 85 76 35 57
DIOVAN 84 83 36 51
VENTOLIN HFA 82 54 37 19
SERTRALINE HCL 82 76 37 33
PLAVIX 80 72 39 71
DIOVAN HCT 79 58 40 84
PANTOPRAZOLE SODIUM 73 62 41 36
ZOLPIDEM TARTRATE 73 63 41 20
METOPROLOL SUCCINATE 68 52 43 45
LOSARTAN POTASSIUM 64 48 44 34
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 48 45 68
SINGULAIR 63 52 45 7
DIGOXIN 62 55 47 55
TAMSULOSIN HCL 60 54 48 39
LANTUS 55 44 49 59
LOSARTAN-HYDROCHLOROTHIAZIDE 54 52 50 83
KLOR-CON M20 53 40 51 129
MONTELUKAST SODIUM 51 35 52 15
NIASPAN 50 44 53 243
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.